Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the coronavirus disease (COVID-19), which poses a major threat to humans worldwide. With the continuous progress of the pandemic, a growing number of people are infected with SARS-CoV-2, including hepatocellular carcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Luhong, Ding, Yinan, Zhang, Chuanyong, Chen, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154116/
https://www.ncbi.nlm.nih.gov/pubmed/35639708
http://dx.doi.org/10.1371/journal.pone.0269249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154116/
https://www.ncbi.nlm.nih.gov/pubmed/35639708
http://dx.doi.org/10.1371/journal.pone.0269249

Ejemplares similares